National Guideline Clearinghouse | Management of a suspicious adnexal mass.

full-text ►
National Guideline Clearinghouse | Management of a suspicious adnexal mass.

Program in Evidence-based Care

• Management of a suspicious adnexal mass.
• The role of IMRT in breast cancer.
• The role of IMRT in gynecologic cancers.
• The role of IMRT in head & neck cancer.
• The role of IMRT in lung cancer.
• The role of IMRT in prostate cancer.
• The role of IMRT in skin cancers.
• The role of IMRT in thyroid cancers.

Guideline Title

Management of a suspicious adnexal mass.

 

 

Bibliographic Source(s)

Dodge J, Covens A, Lacchetti C, Elit L, Le T, Devries-Aboud M, Fung Kee Fung M, Gynecology Cancer Disease Site Group. Management of a suspicious adnexal mass. Toronto (ON): Cancer Care Ontario (CCO); 2011 Jul 7. Various p. (Evidence-based series; no. 4-15).  [294 references]

 

 

Guideline Status

This is the current release of the guideline.
The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.
Please visit the Cancer Care Ontario Web site  for details on any new evidence that has emerged and implications to the guidelines.
https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=100599